244 related articles for article (PubMed ID: 16161993)
21. Multifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacer.
Fu F; Wu Y; Zhu J; Wen S; Shen M; Shi X
ACS Appl Mater Interfaces; 2014 Sep; 6(18):16416-25. PubMed ID: 25185074
[TBL] [Abstract][Full Text] [Related]
22. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.
He X; Alves CS; Oliveira N; Rodrigues J; Zhu J; Bányai I; Tomás H; Shi X
Colloids Surf B Biointerfaces; 2015 Jan; 125():82-9. PubMed ID: 25437067
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of anionic half generation 3.5-6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin.
Kirkpatrick GJ; Plumb JA; Sutcliffe OB; Flint DJ; Wheate NJ
J Inorg Biochem; 2011 Sep; 105(9):1115-22. PubMed ID: 21704583
[TBL] [Abstract][Full Text] [Related]
24. Targeted dendrimeric anticancer prodrug: a methotrexate-folic acid-poly(amidoamine) conjugate and a novel, rapid, "one pot" synthetic approach.
Zhang Y; Thomas TP; Desai A; Zong H; Leroueil PR; Majoros IJ; Baker JR
Bioconjug Chem; 2010 Mar; 21(3):489-95. PubMed ID: 20128612
[TBL] [Abstract][Full Text] [Related]
25. Multifunctional dendrimer-modified multiwalled carbon nanotubes: synthesis, characterization, and in vitro cancer cell targeting and imaging.
Shi X; Wang SH; Shen M; Antwerp ME; Chen X; Li C; Petersen EJ; Huang Q; Weber WJ; Baker JR
Biomacromolecules; 2009 Jul; 10(7):1744-50. PubMed ID: 19459647
[TBL] [Abstract][Full Text] [Related]
26. Preparation, cellular transport, and activity of polyamidoamine-based dendritic nanodevices with a high drug payload.
Kolhe P; Khandare J; Pillai O; Kannan S; Lieh-Lai M; Kannan RM
Biomaterials; 2006 Feb; 27(4):660-9. PubMed ID: 16054211
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and assessment of first-generation polyamidoamine dendrimer prodrugs to enhance the cellular permeability of P-gp substrates.
Najlah M; Freeman S; Attwood D; D'Emanuele A
Bioconjug Chem; 2007; 18(3):937-46. PubMed ID: 17355118
[TBL] [Abstract][Full Text] [Related]
28. Dendrimer versus linear conjugate: Influence of polymeric architecture on the delivery and anticancer effect of paclitaxel.
Khandare JJ; Jayant S; Singh A; Chandna P; Wang Y; Vorsa N; Minko T
Bioconjug Chem; 2006; 17(6):1464-72. PubMed ID: 17105225
[TBL] [Abstract][Full Text] [Related]
29. Preclinical antitumor efficacy evaluation of dendrimer-based methotrexate conjugates.
Myc A; Douce TB; Ahuja N; Kotlyar A; Kukowska-Latallo J; Thomas TP; Baker JR
Anticancer Drugs; 2008 Feb; 19(2):143-9. PubMed ID: 18176110
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, cellular transport, and activity of polyamidoamine dendrimer-methylprednisolone conjugates.
Khandare J; Kolhe P; Pillai O; Kannan S; Lieh-Lai M; Kannan RM
Bioconjug Chem; 2005; 16(2):330-7. PubMed ID: 15769086
[TBL] [Abstract][Full Text] [Related]
31. Dendrimer-based targeted delivery of an apoptotic sensor in cancer cells.
Myc A; Majoros IJ; Thomas TP; Baker JR
Biomacromolecules; 2007 Jan; 8(1):13-8. PubMed ID: 17206782
[TBL] [Abstract][Full Text] [Related]
32. Solubilization and anticancer-activity enhancement of Methotrexate by novel dendrimeric nanodevices synthesized in one-step reaction.
Soto-Castro D; Cruz-Morales JA; Ramírez Apan MT; Guadarrama P
Bioorg Chem; 2012; 41-42():13-21. PubMed ID: 22341897
[TBL] [Abstract][Full Text] [Related]
33. Arginine-terminated generation 4 PAMAM dendrimer as an effective nanovector for functional siRNA delivery in vitro and in vivo.
Liu C; Liu X; Rocchi P; Qu F; Iovanna JL; Peng L
Bioconjug Chem; 2014 Mar; 25(3):521-32. PubMed ID: 24494983
[TBL] [Abstract][Full Text] [Related]
34. Bifunctional PAMAM dendrimer conjugates of folic acid and methotrexate with defined ratio.
Zong H; Thomas TP; Lee KH; Desai AM; Li MH; Kotlyar A; Zhang Y; Leroueil PR; Gam JJ; Banaszak Holl MM; Baker JR
Biomacromolecules; 2012 Apr; 13(4):982-91. PubMed ID: 22360561
[TBL] [Abstract][Full Text] [Related]
35. Surface-modified and internally cationic polyamidoamine dendrimers for efficient siRNA delivery.
Patil ML; Zhang M; Betigeri S; Taratula O; He H; Minko T
Bioconjug Chem; 2008 Jul; 19(7):1396-403. PubMed ID: 18576676
[TBL] [Abstract][Full Text] [Related]
36. Activity of dendrimer-methotrexate conjugates on methotrexate-sensitive and -resistant cell lines.
Gurdag S; Khandare J; Stapels S; Matherly LH; Kannan RM
Bioconjug Chem; 2006; 17(2):275-83. PubMed ID: 16536456
[TBL] [Abstract][Full Text] [Related]
37. Cellular uptake of glucoheptoamidated poly(amidoamine) PAMAM G3 dendrimer with amide-conjugated biotin, a potential carrier of anticancer drugs.
Uram Ł; Szuster M; Filipowicz A; Zaręba M; Wałajtys-Rode E; Wołowiec S
Bioorg Med Chem; 2017 Jan; 25(2):706-713. PubMed ID: 27919613
[TBL] [Abstract][Full Text] [Related]
38. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases.
Low PS; Henne WA; Doorneweerd DD
Acc Chem Res; 2008 Jan; 41(1):120-9. PubMed ID: 17655275
[TBL] [Abstract][Full Text] [Related]
39. Polyamidoamine dendrimer conjugated chitosan nanoparticles for the delivery of methotrexate.
Leng ZH; Zhuang QF; Li YC; He Z; Chen Z; Huang SP; Jia HY; Zhou JW; Liu Y; Du LB
Carbohydr Polym; 2013 Oct; 98(1):1173-8. PubMed ID: 23987460
[TBL] [Abstract][Full Text] [Related]
40. Design considerations for PAMAM dendrimer therapeutics.
Goonewardena SN; Kratz JD; Zong H; Desai AM; Tang S; Emery S; Baker JR; Huang B
Bioorg Med Chem Lett; 2013 May; 23(10):2872-5. PubMed ID: 23583511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
